In addition to germline mutations in the CDKN2A exon, SNPs predisposed to B-ALL have been identified in introns and noncoding regions such as promoters (Sherborne et al. 2010). The gene discussed is CDKN2A; the disease is precursor B-cell acute lymphoblastic leukemia.